Uta Griesenbach

Uta is a Professor in Molecular Medicine  at Imperial College London, Ex-President of the British Society for Gene and Cell Therapy (2017 to 2021) and a Director (non-excecutive) of the Cell and Gene Therapy Catapult. Uta has over 20 years experience in developing advanced therapeutic medicines. Her reserach interests are related to the development of gene and cell therapy-based treatments for cystic fibrosis and other lung diseases. As part of her translational research, Uta has overseen vector and biomarker development, toxicology studies, as well as GMP vector manufacturing. Uta is Co-Investigator on several gene therapy trials. Uta is a Strategy Group Member of the UK Respiratory Gene Therapy Consortium. In addition, Uta is interested in teaching and work-force development. She is Deputy-director for post-graduate reserach at the National Heart and Lung Institute, Programme director for the MSc in Genes, Drugs and Stem cells-Novel Therapies at Imperial College and chairs the Pan-UK working group for ATMP workforce training.